1. Home
  2. INDP vs DUO Comparison

INDP vs DUO Comparison

Compare INDP & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • DUO
  • Stock Information
  • Founded
  • INDP 2000
  • DUO 2011
  • Country
  • INDP United States
  • DUO China
  • Employees
  • INDP N/A
  • DUO N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • DUO Real Estate
  • Sector
  • INDP Health Care
  • DUO Finance
  • Exchange
  • INDP Nasdaq
  • DUO Nasdaq
  • Market Cap
  • INDP 6.0M
  • DUO 6.1M
  • IPO Year
  • INDP N/A
  • DUO 2019
  • Fundamental
  • Price
  • INDP $2.40
  • DUO $3.44
  • Analyst Decision
  • INDP Strong Buy
  • DUO
  • Analyst Count
  • INDP 2
  • DUO 0
  • Target Price
  • INDP $238.00
  • DUO N/A
  • AVG Volume (30 Days)
  • INDP 77.0K
  • DUO 6.0M
  • Earning Date
  • INDP 08-13-2025
  • DUO 08-29-2025
  • Dividend Yield
  • INDP N/A
  • DUO N/A
  • EPS Growth
  • INDP N/A
  • DUO N/A
  • EPS
  • INDP N/A
  • DUO N/A
  • Revenue
  • INDP N/A
  • DUO $56,189,313.00
  • Revenue This Year
  • INDP N/A
  • DUO N/A
  • Revenue Next Year
  • INDP N/A
  • DUO N/A
  • P/E Ratio
  • INDP N/A
  • DUO N/A
  • Revenue Growth
  • INDP N/A
  • DUO 48.30
  • 52 Week Low
  • INDP $2.47
  • DUO $1.24
  • 52 Week High
  • INDP $58.24
  • DUO $74.72
  • Technical
  • Relative Strength Index (RSI)
  • INDP 18.11
  • DUO 59.78
  • Support Level
  • INDP $6.26
  • DUO $3.24
  • Resistance Level
  • INDP $6.65
  • DUO $5.34
  • Average True Range (ATR)
  • INDP 0.69
  • DUO 0.77
  • MACD
  • INDP -0.33
  • DUO 0.21
  • Stochastic Oscillator
  • INDP 1.86
  • DUO 52.73

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

Share on Social Networks: